Satralizumab is the first and only at-home subcutaneous treatment cleared by the FDA for adults with thyroid eye disease

552c7ae14Space

Health

Health news, debates, and claims covering public health, mental health, nutrition, medical care, and health policy.

1 debate·6,984 claims·43 news stories

0